BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 19995363)

  • 1. Destination therapy: one-year outcomes in patients with a body mass index greater than 30.
    Coyle LA; Ising MS; Gallagher C; Bhat G; Kurien S; Sobieski MA; Slaughter MS
    Artif Organs; 2010 Feb; 34(2):93-7. PubMed ID: 19995363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extremes of body mass index do not impact mid-term survival after continuous-flow left ventricular assist device implantation.
    Brewer RJ; Lanfear DE; Sai-Sudhakar CB; Sundareswaran KS; Ravi Y; Farrar DJ; Slaughter MS
    J Heart Lung Transplant; 2012 Feb; 31(2):167-72. PubMed ID: 22305378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity as a Risk Factor for Consideration for Left Ventricular Assist Devices.
    Mohamedali B; Yost G; Bhat G
    J Card Fail; 2015 Oct; 21(10):800-5. PubMed ID: 26093334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.
    Lietz K; Long JW; Kfoury AG; Slaughter MS; Silver MA; Milano CA; Rogers JG; Naka Y; Mancini D; Miller LW
    Circulation; 2007 Jul; 116(5):497-505. PubMed ID: 17638928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular assist device destination therapy versus extended criteria cardiac transplant.
    Daneshmand MA; Rajagopal K; Lima B; Khorram N; Blue LJ; Lodge AJ; Hernandez AF; Rogers JG; Milano CA
    Ann Thorac Surg; 2010 Apr; 89(4):1205-9; discussion 1210. PubMed ID: 20338335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body mass index and outcome after ventricular assist device placement.
    Musci M; Loforte A; Potapov EV; Krabatsch T; Weng Y; Pasic M; Hetzer R
    Ann Thorac Surg; 2008 Oct; 86(4):1236-42. PubMed ID: 18805168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. End-organ function in patients on long-term circulatory support with continuous- or pulsatile-flow assist devices.
    Radovancevic B; Vrtovec B; de Kort E; Radovancevic R; Gregoric ID; Frazier OH
    J Heart Lung Transplant; 2007 Aug; 26(8):815-8. PubMed ID: 17692785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving outcomes with long-term "destination" therapy using left ventricular assist devices.
    Long JW; Healy AH; Rasmusson BY; Cowley CG; Nelson KE; Kfoury AG; Clayson SE; Reid BB; Moore SA; Blank DU; Renlund DG
    J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1353-60; discussion 1360-1. PubMed ID: 18544385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body mass index and outcomes after left ventricular assist device placement.
    Butler J; Howser R; Portner PM; Pierson RN
    Ann Thorac Surg; 2005 Jan; 79(1):66-73. PubMed ID: 15620917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk assessment for continuous flow left ventricular assist devices: does the destination therapy risk score work? An analysis of over 1,000 patients.
    Teuteberg JJ; Ewald GA; Adamson RM; Lietz K; Miller LW; Tatooles AJ; Kormos RL; Sundareswaran KS; Farrar DJ; Rogers JG
    J Am Coll Cardiol; 2012 Jul; 60(1):44-51. PubMed ID: 22541834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of center volume on outcomes of left ventricular assist device implantation as destination therapy: analysis of the Thoratec HeartMate Registry, 1998 to 2005.
    Lietz K; Long JW; Kfoury AG; Slaughter MS; Silver MA; Milano CA; Rogers JG; Miller LW; Deng M; Naka Y; Mancini D
    Circ Heart Fail; 2009 Jan; 2(1):3-10. PubMed ID: 19808309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left ventricular assist device in patients with body mass index greater than 30 as bridge to weight loss and heart transplant candidacy.
    Yanagida R; Czer LS; Mirocha J; Rafiei M; Esmailian F; Moriguchi J; Kobashigawa JA; Trento A
    Transplant Proc; 2014 Dec; 46(10):3575-9. PubMed ID: 25498092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical strategies and outcomes in advanced heart failure patients older than 70 years of age receiving the HeartMate II left ventricular assist device: a community hospital experience.
    Adamson RM; Stahovich M; Chillcott S; Baradarian S; Chammas J; Jaski B; Hoagland P; Dembitsky W
    J Am Coll Cardiol; 2011 Jun; 57(25):2487-95. PubMed ID: 21679851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Body Mass Index on Outcomes in Left Ventricular Assist Device Recipients.
    Go PH; Nemeh HW; Borgi J; Paone G; Morgan JA
    J Card Surg; 2016 Apr; 31(4):242-7. PubMed ID: 26856974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Right heart failure and "failure to thrive" after left ventricular assist device: clinical predictors and outcomes.
    Baumwol J; Macdonald PS; Keogh AM; Kotlyar E; Spratt P; Jansz P; Hayward CS
    J Heart Lung Transplant; 2011 Aug; 30(8):888-95. PubMed ID: 21530314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hospital costs for left ventricular assist devices for destination therapy: lower costs for implantation in the post-REMATCH era.
    Miller LW; Nelson KE; Bostic RR; Tong K; Slaughter MS; Long JW
    J Heart Lung Transplant; 2006 Jul; 25(7):778-84. PubMed ID: 16818120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in renal function after implantation of continuous-flow left ventricular assist devices.
    Hasin T; Topilsky Y; Schirger JA; Li Z; Zhao Y; Boilson BA; Clavell AL; Rodeheffer RJ; Frantz RP; Edwards BS; Pereira NL; Joyce L; Daly R; Park SJ; Kushwaha SS
    J Am Coll Cardiol; 2012 Jan; 59(1):26-36. PubMed ID: 22192665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanical circulatory support as a bridge to transplant candidacy.
    Elhenawy AM; Algarni KD; Rodger M; Maciver J; Maganti M; Cusimano RJ; Yau TM; Delgado DH; Ross HJ; Rao V
    J Card Surg; 2011 Sep; 26(5):542-7. PubMed ID: 21883463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.